ETERNAL's 7th newsletter brings news of newly published research results reporting how the enzymatic (laccase-mediated) transformation has been used to breakdown the antidepressant trazodone hydrochloride and its associated by-products, along with several new resources and routes to find out more about the broad impact being achieved across ETERNAL's industrial case studies. You can also find out more about the social and behavioural aspects of change being explored in the project’s Change Labs through interventions for healthcare practioners and patients.
This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy.
By clicking Accept, you consent to our use of cookies.
